Cancer Biology Research in District of Columbia
Cancer Biology Research (93.396) awarded $27.7 million to recipients in District of Columbia in 23 grants from fiscal 2021 to 2025, 0.6% of the program's national total. Georgetown University received the most, $14.1 million.
- Awarded in District of Columbia$27.7 million
- Awards23
- Share of the program0.6%
- Rank among states27th of 50
- National total$4.3 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 11 | $4.6 million |
| FY 2022 | 7 | $3.1 million |
| FY 2023 | 10 | $4.7 million |
| FY 2024 | 16 | $7.8 million |
| FY 2025 | 15 | $7.6 million |
Recipients in District of Columbia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Georgetown University | Colleges and universities | 10 | $14.1 million |
| George Washington University (the) | Colleges and universities | 11 | $12.6 million |
| Howard University | Colleges and universities | 1 | $576,824 |
| Catholic University of America (the) | Colleges and universities | 1 | $414,060 |
Open opportunities under this program
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much Cancer Biology Research money goes to District of Columbia?
$27.7 million from fiscal 2021 to 2025, across 23 awards. District of Columbia ranks 27th of 50 states and territories for this program.
Who receives Cancer Biology Research money in District of Columbia?
The largest recipient is Georgetown University, with $14.1 million in 10 awards. Next are George Washington University (the) and Howard University.
Can organizations in District of Columbia apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Biology Research in other states
Other large programs in District of Columbia
- National Railroad Passenger Corporation Grants
- Grants to States for Medicaid
- USAID Foreign Assistance for Programs Overseas
- Federal-State Partnership for Intercity Passenger Rail
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Federal Transit Formula Grants
- International Programs to Support Democracy, Human Rights and Labor
- Environmental and Scientific Partnerships and Programs
- International Broadcasting Independent Grantee Organizations
- Highway Planning and Construction